QA: Omeros CORP in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001285819_2019_Omeros_CORP.pdf

Logs

Graph

Absolute values for 0001285819, Omeros CORP

  xvar xval
0 AssetsCurrent 89,867,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,845,000
3 remainder_Assets 2,224,000
4 LiabilitiesCurrent 37,356,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 512,000
8 SellingGeneralAndAdministrativeExpense 50,997,224
9 ResearchAndDevelopmentExpense 133,025,590
10 remainder_Expenses 4,416,787
11 remainder_Revenues 24,751,366
12 remainder_NetIncome -5,085,091
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 95,936,000
1 Liabilities 37,356,000
2 Expenses 188,951,601
3 Revenues 24,751,366
4 StockholdersEquity 58,580,000
5 NetIncome -169,285,326
6 ComprehensiveNetIncome -169,285,326
7 BaseVar 176,040,029
8 EconomicCapitalRatiobeforeLimitedLiability -0.624
9 EconomicCapitalRatio 1.37

Edgar->Model Mapping

Feature Distribution

Change over Time